Skip to content

Effect of Two Different Devices used to Secure Airway during Surgery (AURAGAIN AND PROSEAL LARYNGEAL MASK AIRWAY) on the blood pressure and heart rate.

A Randomised Controlled Trial Comparing Haemodynamic Response After Insertion of Auragain And Proseal Laryngeal Mask Airway - NIL

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/066336
Enrollment
80
Registered
2024-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Proseal LMA: Proseal LMA will be inserted for securing the airway as per routine clinical procedure (inserted after induction of anaesthesia and maintained so till end of surgery). Cont

Sponsors

University College of Medical Sciences and GTB Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with ASA physical status I/II/III , mouth opening more than 2 finger breadth, who are known hypertensives and scheduled for elective surgery with supraglottic airway devices as airway device will be included.

Exclusion criteria

Exclusion criteria: Those who are obese ,pregnant, have known chronic obstructive pulmonary disease,asthma or any other respiratory pathology,or history suggestive of gastrooesophageal reflux disease

Design outcomes

Primary

MeasureTime frame
Mean Arterial Pressure (MAP)Timepoint: 0 minute after airway insertion (Proseal LMA or AMBU Aura Gain)

Secondary

MeasureTime frame
Systolic Blood Pressure, Diastolic Blood Pressure, & Heart RateTimepoint: Immediately following, & then at 1, 3, 5, 10 mins after insertion of AMBU Aura Gain & Proseal LMA

Countries

India

Contacts

Public ContactSiva. S

University College of Medical Sciences and GTB Hospital

drashatyagi@gmail.com01122692415

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026